Andrea Züger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea Züger has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Katja Mehlis
Department of Medical Oncology, Section Translational Medical Ethics, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
4 shared publications- Katja Mehlis
Faculty of Medicine, Institute for Medical and Data Ethics Heidelberg University Heidelberg Germany
4 shared publications - Eva Caroline Winkler
Heidelberg University, Faculty of Medicine, Institute for Medical and Data Ethics, Heidelberg, Germany
3 shared publications Eva Winkler
Department of Medical Oncology, Section Translational Medical Ethics, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
3 shared publicationsLuise Richter
Methods in Empirical Social Research, Institute of Sociology, Faculty of Arts, Humanities and Social Science, Dresden University of Technology, Dresden, Germany
3 shared publicationsSophie Pauge
Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany
3 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Springer Nature in Ethik in der Medizin
- p. 1-20
„Was hat Sie heute irritiert?“ – Die Bedeutung (subtiler) Irritationserfahrungen für die medizinethische Lehre
Zusammenfassung: Der Artikel plädiert für eine stärkere Berücksichtigung moralischer Alltagserfahrungen in der medizinethischen Lehre und kritisiert den in medizinethischen Debatten dominierenden Fokus auf Dilemmasituationen und Entscheidungslogiken. Ausgangspunkt ist die Annahme, dass der medizinische Berufs- und Studienalltag nicht nur aus Entscheidungssituationen besteht, sondern auch von Verunsicherungen, diffusem Unbehagen und ambivalenten Gefühlen geprägt ist. Solche Erfahrungen werden im vorliegenden Beitrag als Irritationserfahrungen konzipiert. In Anlehnung an die Bildungsforschung zeigt der Beitrag das Potenzial von Irritationserfahrungen auf. Zugleich geht der Beitrag auf das Verhältnis von Irritationserfahrungen und der epistemischen Logik einer Medizin als Handlungswissenschaft ein. Abschließend skizziert der Artikel, wie Irritationserfahrungen in der medizinethischen Lehre durch ethnografische Übungen verankert werden können. Der Beitrag endet mit der Forderung nach mehr Freiräumen für Irritationen im Medizinstudium.
- 26 October 2026
- Published by Springer Nature in Ethik in der Medizin
- p. 1-20
Open Access„Was hat Sie heute irritiert?“ – Die Bedeutung (subtiler) Irritationserfahrungen für die medizinethische Lehre
Zusammenfassung: Der Artikel plädiert für eine stärkere Berücksichtigung moralischer Alltagserfahrungen in der medizinethischen Lehre und kritisiert den in medizinethischen Debatten dominierenden Fokus auf Dilemmasituationen und Entscheidungslogiken. Ausgangspunkt ist die Annahme, dass der medizinische Berufs- und Studienalltag nicht nur aus Entscheidungssituationen besteht, sondern auch von Verunsicherungen, diffusem Unbehagen und ambivalenten Gefühlen geprägt ist. Solche Erfahrungen werden im vorliegenden Beitrag als Irritationserfahrungen konzipiert. In Anlehnung an die Bildungsforschung zeigt der Beitrag das Potenzial von Irritationserfahrungen auf. Zugleich geht der Beitrag auf das Verhältnis von Irritationserfahrungen und der epistemischen Logik einer Medizin als Handlungswissenschaft ein. Abschließend skizziert der Artikel, wie Irritationserfahrungen in der medizinethischen Lehre durch ethnografische Übungen verankert werden können. Der Beitrag endet mit der Forderung nach mehr Freiräumen für Irritationen im Medizinstudium.
- Open Access
- 30 July 2026
- Published by Wiley in Health Expectations
- Vol. 29 (4) , e70789
Evaluating the Quality and Impact of Online Patient Forums in Genomic Data Governance
Background: There is consensus that patients' perspectives should be considered in decisions about health data. Deliberative forums (DFs) have become a common tool for patient involvement (PI) in health policy development. However, translating deliberative outcomes into policy decisions poses challenges. There has recently been interest in conducting DFs online, yet few online DFs have been evaluated for quality or policy impact. We evaluated a series of online DFs that were conducted to explore how patients can be involved in the governance of a genomic data archive (GDA), the German Human Genome‐Phenome Archive (GHGA). Methods: We conducted two online DFs and a follow‐up dialogue event with members of the cancer and rare diseases (RD) communities in Germany ( n = 26). Evaluation was conducted using three approaches: (1) A pre‐/post‐survey that assessed the knowledge and opinions of the participants before and after the forums; (2) the OECD questionnaire for deliberative processes, which evaluates the design of the DFs and the deliberative experience from the participants' perspective, and (3) assessment of the pathway to impact of the DFs in terms of which deliberative outcomes the management of the GHGA committed to acting on as documented in a white paper, and which of these, at the time of writing, have been acted upon, or implemented as its governance policy. Results: Eighteen participants (69%) completed the survey on knowledge and opinions. A Wilcoxon Signed‐Rank Test indicated a statistically significant knowledge gain for all items in the knowledge category ( p < 0.05). There was a significant change in one of the opinion items in the survey. A total of 24 participants (96%) completed the OECD survey; 21 participants (87.5%) reported that the deliberations and their outcome met their expectations. The participants made 14 recommendations for the PI policy of the GHGA. The GHGA management committed to 13 of the 14 recommendations from the DFs. These recommendations were incorporated into a white paper proposing a policy framework on PI in the governance of the GHGA. We identified 7 recommendations from the white paper that have been acted upon by the GHGA or implemented as part of its policy. Conclusions: Online DFs can achieve high deliberative quality and meaningfully influence decision‐making about governance and policy development. Our findings demonstrate the feasibility of online patient participation in health data governance and offer empirically grounded insights for the translation of patient and public deliberation outcomes into policy‐making and governance processes.
- 30 July 2026
- Published by Wiley in Health Expectations
- Vol. 29 (4) , e70789
Open AccessEvaluating the Quality and Impact of Online Patient Forums in Genomic Data Governance
Background: There is consensus that patients' perspectives should be considered in decisions about health data. Deliberative forums (DFs) have become a common tool for patient involvement (PI) in health policy development. However, translating deliberative outcomes into policy decisions poses challenges. There has recently been interest in conducting DFs online, yet few online DFs have been evaluated for quality or policy impact. We evaluated a series of online DFs that were conducted to explore how patients can be involved in the governance of a genomic data archive (GDA), the German Human Genome‐Phenome Archive (GHGA). Methods: We conducted two online DFs and a follow‐up dialogue event with members of the cancer and rare diseases (RD) communities in Germany ( n = 26). Evaluation was conducted using three approaches: (1) A pre‐/post‐survey that assessed the knowledge and opinions of the participants before and after the forums; (2) the OECD questionnaire for deliberative processes, which evaluates the design of the DFs and the deliberative experience from the participants' perspective, and (3) assessment of the pathway to impact of the DFs in terms of which deliberative outcomes the management of the GHGA committed to acting on as documented in a white paper, and which of these, at the time of writing, have been acted upon, or implemented as its governance policy. Results: Eighteen participants (69%) completed the survey on knowledge and opinions. A Wilcoxon Signed‐Rank Test indicated a statistically significant knowledge gain for all items in the knowledge category ( p < 0.05). There was a significant change in one of the opinion items in the survey. A total of 24 participants (96%) completed the OECD survey; 21 participants (87.5%) reported that the deliberations and their outcome met their expectations. The participants made 14 recommendations for the PI policy of the GHGA. The GHGA management committed to 13 of the 14 recommendations from the DFs. These recommendations were incorporated into a white paper proposing a policy framework on PI in the governance of the GHGA. We identified 7 recommendations from the white paper that have been acted upon by the GHGA or implemented as part of its policy. Conclusions: Online DFs can achieve high deliberative quality and meaningfully influence decision‐making about governance and policy development. Our findings demonstrate the feasibility of online patient participation in health data governance and offer empirically grounded insights for the translation of patient and public deliberation outcomes into policy‐making and governance processes.
- Open Access
- 27 July 2026
- Published by Elsevier in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
- Vol. 205, 70-79
Würdebewahren im Gesundheitswesen – Konzeption und Pilotierung einer Inhouse-Schulung für Fachpersonen im Gesundheitswesen
- 27 July 2026
- Published by Elsevier in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
- Vol. 205, 70-79
Open AccessWürdebewahren im Gesundheitswesen – Konzeption und Pilotierung einer Inhouse-Schulung für Fachpersonen im Gesundheitswesen
- Open Access
- 12 February 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (3) , 190
Towards the assessment of financial distress among cancer patients: a conceptual model of the financial effects of a tumour disease
Purpose: A conceptualisation of subjective financial distress as a consequence of a cancer diagnosis and treatment is still missing due to a lack of a comprehensive model accounting for all relevant dimensions of financial effects of cancer experienced by patients. Our goal was to derive a model for the German healthcare system to shed light on the complex process of financial effects of cancer. Methods: The model was developed through systematic literature review and qualitative studies, including interviews with 18 cancer patients and a focus group with 4 social services representatives. The iterative process of model development was accompanied by an ongoing exchange in the interdisciplinary research team. Results: The developed model of financial effects of cancer experienced by patients consists of three dimensions: (1) actual and anticipated financial disadvantages , (2) behavioural and cognitive coping strategies , and (3) subjective financial distress conceptualised as negative effects in different aspects of daily living: employment , living situation , family , social participation , health promoting lifestyle , additional personally preferred treatments , navigating the health system , and a further area so-called unspecific. Conclusion: Subjective financial distress is driven by different financial effects of cancer experienced by patients and is perceived as negative in various aspects of daily living. While the identified categories of daily living can be observed in countries with universal healthcare coverage, the content and degree of each subcategory depend on country-specific characteristics. The introduced model can be used to inform the development of a new patient-reported outcome measure (PROM). Trial registration number: NCT05319925 (registration date, 2022-06-01)
- 12 February 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (3) , 190
Open AccessTowards the assessment of financial distress among cancer patients: a conceptual model of the financial effects of a tumour disease
Purpose: A conceptualisation of subjective financial distress as a consequence of a cancer diagnosis and treatment is still missing due to a lack of a comprehensive model accounting for all relevant dimensions of financial effects of cancer experienced by patients. Our goal was to derive a model for the German healthcare system to shed light on the complex process of financial effects of cancer. Methods: The model was developed through systematic literature review and qualitative studies, including interviews with 18 cancer patients and a focus group with 4 social services representatives. The iterative process of model development was accompanied by an ongoing exchange in the interdisciplinary research team. Results: The developed model of financial effects of cancer experienced by patients consists of three dimensions: (1) actual and anticipated financial disadvantages , (2) behavioural and cognitive coping strategies , and (3) subjective financial distress conceptualised as negative effects in different aspects of daily living: employment , living situation , family , social participation , health promoting lifestyle , additional personally preferred treatments , navigating the health system , and a further area so-called unspecific. Conclusion: Subjective financial distress is driven by different financial effects of cancer experienced by patients and is perceived as negative in various aspects of daily living. While the identified categories of daily living can be observed in countries with universal healthcare coverage, the content and degree of each subcategory depend on country-specific characteristics. The introduced model can be used to inform the development of a new patient-reported outcome measure (PROM). Trial registration number: NCT05319925 (registration date, 2022-06-01)
- Open Access
- 8 May 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (5)
Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study
Background: The incidence of colorectal carcinoma (CRC) in patients ≤50 (early-onset-CRC, EOCRC) years is increasing. Given their different phase of life, younger individuals may face specific challenges in terms of body image, professional life, and psychosocial support. However, tailored programs for EOCRC patients are lacking in Germany. JUMP-START, a prospective study at the National Center for Tumor Diseases (NCT) Heidelberg in collaboration with the AIO (Arbeitsgemeinschaft internistische Onkologie) and the foundation for young adults with cancer in Germany aims to identify the specific needs of EOCRC patients and improve multiprofessional care. Materials and Methods: Semi-structured interviews were conducted until content saturation, based on an interview guide focused on challenges related to diagnosis, utilization of support programs, and unmet needs. The interview guide was developed in an expert and patient panelist discussion. Qualitative analysis was performed with MAXQDA, using a content structuring qualitative content analysis according to Kuckartz. Results: Forty-three EOCRC patients were screened, and 14 participants were interviewed at NCT Heidelberg between October 2023 and January 2024. Three main themes emerged: (1) The impact of CRC diagnosis at an early age on psychological and physical health, daily routine, and future perspectives, (2) Experiences with care service access and utility, and (3) Expectations for a multiprofessional care at a dedicated EOCRC center. Conclusions: EOCRC patients highlighted various age-group-specific challenges related to diagnosis and treatment. Tailored multiprofessional programs may optimize care for EOCRC patients.
- 8 May 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (5)
Open AccessOptimization of multiprofessional care for young colorectal cancer patients: a qualitative Study
Background: The incidence of colorectal carcinoma (CRC) in patients ≤50 (early-onset-CRC, EOCRC) years is increasing. Given their different phase of life, younger individuals may face specific challenges in terms of body image, professional life, and psychosocial support. However, tailored programs for EOCRC patients are lacking in Germany. JUMP-START, a prospective study at the National Center for Tumor Diseases (NCT) Heidelberg in collaboration with the AIO (Arbeitsgemeinschaft internistische Onkologie) and the foundation for young adults with cancer in Germany aims to identify the specific needs of EOCRC patients and improve multiprofessional care. Materials and Methods: Semi-structured interviews were conducted until content saturation, based on an interview guide focused on challenges related to diagnosis, utilization of support programs, and unmet needs. The interview guide was developed in an expert and patient panelist discussion. Qualitative analysis was performed with MAXQDA, using a content structuring qualitative content analysis according to Kuckartz. Results: Forty-three EOCRC patients were screened, and 14 participants were interviewed at NCT Heidelberg between October 2023 and January 2024. Three main themes emerged: (1) The impact of CRC diagnosis at an early age on psychological and physical health, daily routine, and future perspectives, (2) Experiences with care service access and utility, and (3) Expectations for a multiprofessional care at a dedicated EOCRC center. Conclusions: EOCRC patients highlighted various age-group-specific challenges related to diagnosis and treatment. Tailored multiprofessional programs may optimize care for EOCRC patients.
- 28 February 2025
- Published by Walter de Gruyter GmbH in Zeitschrift für medizinische Ethik
- Vol. 71 (1) , 32-52
Subjektivität und Kontext: Überlegungen und Empfehlungen zur medizinethischen Begutachtung qualitativer Forschung
Der Artikel beleuchtet die Herausforderungen der medizinethischen Begutachtung qualitativer Forschung, die durch einen offenen und zirkulären Ansatz geprägt ist und ein Erkenntnisinteresse für Subjektivität in spezifischen Kontexten hat. Während die Begutachtung bisher stark an standardisierten, quantitativen Ansätzen orientiert ist, empfehlen die Autor:innen eine Anpassung des Prüfverfahrens, um den Gütekriterien qualitativer Forschung Rechnung zu tragen, Forschungsprojekte adäquat auf ihre ethische Vertretbarkeit zu prüfen und Forschende in ihrem Vorgehen zu befähigen.
- 28 February 2025
- Published by Walter de Gruyter GmbH in Zeitschrift für medizinische Ethik
- Vol. 71 (1) , 32-52
Subjektivität und Kontext: Überlegungen und Empfehlungen zur medizinethischen Begutachtung qualitativer Forschung
Der Artikel beleuchtet die Herausforderungen der medizinethischen Begutachtung qualitativer Forschung, die durch einen offenen und zirkulären Ansatz geprägt ist und ein Erkenntnisinteresse für Subjektivität in spezifischen Kontexten hat. Während die Begutachtung bisher stark an standardisierten, quantitativen Ansätzen orientiert ist, empfehlen die Autor:innen eine Anpassung des Prüfverfahrens, um den Gütekriterien qualitativer Forschung Rechnung zu tragen, Forschungsprojekte adäquat auf ihre ethische Vertretbarkeit zu prüfen und Forschende in ihrem Vorgehen zu befähigen.
- Open Access
Self-reported determinants for subjective financial distress: a qualitative interview study with German cancer patients
Objectives: Patient-reported financial effects of a tumour disease in a universal healthcare setting are a multidimensional phenomenon. Actual and anticipated objective financial burden caused by direct medical and non-medical costs as well as indirect costs such as loss of income can lead to subjective financial distress. To better understand subjective financial distress, the presented study explores self-reported determinants for subjective financial distress in German patients with cancer, aiming to inform a new German-language patient-reported outcome measure for determining the financial effects of a tumour disease. Design: Semistructured interviews with n=18 patients with cancer were conducted between May 2021 and December 2021. Patients were recruited based on a purposive sampling strategy in outpatient and inpatient settings. The interviews were audiorecorded, transcribed verbatim and analysed using qualitative content analysis. Setting: Participants were recruited from two German academic cancer centres, that is, the National Center for Tumor Diseases Heidelberg and Jena University Hospital. Participants: 18 patients who had undergone cancer-related therapy for at least 2 months were interviewed (10 females). Results: Based on the results of the qualitative content analysis, we developed a multicomponent construct of determinants that could influence subjective financial distress. The self-reported determinants can be classified into material ( savings, good salary, shared rent through shared living, employed partner, paid-off house, potential financial support from family and friends, work-related specifics, consumer restrictions, out-of-pocket-costs and anticipated financial changes ), social ( social support from friends and family ), systemic ( administrative hurdlers and insurance cover ) and inner personal determinants ( coping strategies, change of attitude, character traits ). Conclusion: Subjective financial distress depends not only on material but also on social, systemic and inner personal determinants. Knowledge of these determinants can inform a new comprehensive German-language instrument for measuring self-reported financial effects of a tumour disease. Trial registration number: NCT05319925 .
Open AccessSelf-reported determinants for subjective financial distress: a qualitative interview study with German cancer patients
Objectives: Patient-reported financial effects of a tumour disease in a universal healthcare setting are a multidimensional phenomenon. Actual and anticipated objective financial burden caused by direct medical and non-medical costs as well as indirect costs such as loss of income can lead to subjective financial distress. To better understand subjective financial distress, the presented study explores self-reported determinants for subjective financial distress in German patients with cancer, aiming to inform a new German-language patient-reported outcome measure for determining the financial effects of a tumour disease. Design: Semistructured interviews with n=18 patients with cancer were conducted between May 2021 and December 2021. Patients were recruited based on a purposive sampling strategy in outpatient and inpatient settings. The interviews were audiorecorded, transcribed verbatim and analysed using qualitative content analysis. Setting: Participants were recruited from two German academic cancer centres, that is, the National Center for Tumor Diseases Heidelberg and Jena University Hospital. Participants: 18 patients who had undergone cancer-related therapy for at least 2 months were interviewed (10 females). Results: Based on the results of the qualitative content analysis, we developed a multicomponent construct of determinants that could influence subjective financial distress. The self-reported determinants can be classified into material ( savings, good salary, shared rent through shared living, employed partner, paid-off house, potential financial support from family and friends, work-related specifics, consumer restrictions, out-of-pocket-costs and anticipated financial changes ), social ( social support from friends and family ), systemic ( administrative hurdlers and insurance cover ) and inner personal determinants ( coping strategies, change of attitude, character traits ). Conclusion: Subjective financial distress depends not only on material but also on social, systemic and inner personal determinants. Knowledge of these determinants can inform a new comprehensive German-language instrument for measuring self-reported financial effects of a tumour disease. Trial registration number: NCT05319925 .
- 8 February 2024
- Published by Springer Nature in Forum
- Vol. 39 (2) , 113-117
Cancer and financial impacts on patients
- 8 February 2024
- Published by Springer Nature in Forum
- Vol. 39 (2) , 113-117
Cancer and financial impacts on patients
- Open Access
- 13 November 2023
- Published by Springer Nature in Der Schmerz
- Vol. 38 (6) , 422-432
Einflussfaktoren auf das Einnahmeverhalten von Analgetika bei Patient*innen mit chronischen tumorassoziierten Schmerzen
Zusammenfassung: Hintergrund: Patient*innen überleben eine Tumorerkrankung durch die Verbesserung der tumorspezifischen Therapie immer länger. Schmerzen sind ein häufiges Symptom. Goldstandard bei tumorassoziierten chronischen Schmerzen ist die multimodale Therapie. Nonadhärenz verursacht hohe Kosten und bringt unter Umständen Patient*innen in Gefahr. Ziel dieser Studie war es, das Einnahmeverhalten und die subjektive Therapietreue von Patient*innen mit tumorassoziierten chronischen Schmerzen zu untersuchen. Dabei sollte die Perspektive der Patient*innen im Mittelpunkt stehen. Verschiedenen Medikamentengruppen, wie Nicht-Opioid-Analgetika (NOPA), Opioide, Ko-Analgetika und Cannabinoide, aber auch nichtmedikamentöse Verfahren wurden in die Betrachtung eingeschlossen. Methode: Im Rahmen eines qualitativen Forschungsansatzes wurden semistrukturierte Leitfadeninterviews mit 10 Patient*innen mit chronischen tumorassoziierten Schmerzen durchgeführt. Das gesprochene Wort wurde aufgenommen und transkribiert. Die Auswertung erfolgte im Sinne einer fokussierten inhaltlich strukturierenden Interviewanalyse nach Kuckartz und Rädiker. Ergebnisse: Es konnten fünf Hauptkategorien definiert werden. Die zentrale Kategorie anhand der Forschungsfrage bildete das „Adhärenzverhalten aus Patient*innensicht“. Den Rahmen der Untersuchung bildete die Kategorie „Medikamentöse Therapie“. Weitere Hauptkategorien waren: „Krankheitsgeschichte“, „Verhältnis zu den Behandelnden“ und „Einstellungen und Überzeugungen“. Insgesamt wurden weitere 77 Unterkategorien gebildet und interpretiert. Das Adhärenzverhalten aus Patient*innensicht unterschied sich zwischen den verschiedenen Medikamentengruppen. Ein palliatives Setting beeinflusste Therapieentscheidungen und Therapieadhärenz. Die angewendeten Medikamentenschemata waren komplex und dynamisch, gerade auch bei mehreren beteiligten Behandelnden. Weiterhin bestand Unklarheit bei der Anwendung von Cannabinoiden. Nichtmedikamentöse Therapien wurden von den Patient*innen marginalisiert. Aus Sicht der befragten Patient*innen waren es weniger die Behandelnden, die Einfluss auf ihr Adhärenzverhalten nahmen, als vielmehr eigene Erfahrungen, Einstellungen und Überzeugungen Diskussion: Die Untersuchung bezog ergänzend zu bisheriger Literatur in einem qualitativen Setting alle Medikamentengruppen und auch nichtmedikamentöse Therapien gleichgestellt mit ein. Aus der bisherigen Forschung bekannte Adhärenzfaktoren spiegelten sich auch in der subjektiven Wahrnehmung der Gruppe der Patient*innen mit chronifizierten Schmerzen nach Tumorerkrankungen wider. Eine Marginalisierung nichtmedikamentöser Verfahren könnte damit erklärt werden, dass in der Phase einer Chronifizierung multimodale Therapieansätze zu selten konsequent eingesetzt und kontrolliert werden. Medikamentöse und nichtmedikamentöse Therapien sollten daher noch konsequenter auch bei Patient*innen mit tumorassoziierten Schmerzen gleichberechtigt angewendet werden.
- 13 November 2023
- Published by Springer Nature in Der Schmerz
- Vol. 38 (6) , 422-432
Open AccessEinflussfaktoren auf das Einnahmeverhalten von Analgetika bei Patient*innen mit chronischen tumorassoziierten Schmerzen
Zusammenfassung: Hintergrund: Patient*innen überleben eine Tumorerkrankung durch die Verbesserung der tumorspezifischen Therapie immer länger. Schmerzen sind ein häufiges Symptom. Goldstandard bei tumorassoziierten chronischen Schmerzen ist die multimodale Therapie. Nonadhärenz verursacht hohe Kosten und bringt unter Umständen Patient*innen in Gefahr. Ziel dieser Studie war es, das Einnahmeverhalten und die subjektive Therapietreue von Patient*innen mit tumorassoziierten chronischen Schmerzen zu untersuchen. Dabei sollte die Perspektive der Patient*innen im Mittelpunkt stehen. Verschiedenen Medikamentengruppen, wie Nicht-Opioid-Analgetika (NOPA), Opioide, Ko-Analgetika und Cannabinoide, aber auch nichtmedikamentöse Verfahren wurden in die Betrachtung eingeschlossen. Methode: Im Rahmen eines qualitativen Forschungsansatzes wurden semistrukturierte Leitfadeninterviews mit 10 Patient*innen mit chronischen tumorassoziierten Schmerzen durchgeführt. Das gesprochene Wort wurde aufgenommen und transkribiert. Die Auswertung erfolgte im Sinne einer fokussierten inhaltlich strukturierenden Interviewanalyse nach Kuckartz und Rädiker. Ergebnisse: Es konnten fünf Hauptkategorien definiert werden. Die zentrale Kategorie anhand der Forschungsfrage bildete das „Adhärenzverhalten aus Patient*innensicht“. Den Rahmen der Untersuchung bildete die Kategorie „Medikamentöse Therapie“. Weitere Hauptkategorien waren: „Krankheitsgeschichte“, „Verhältnis zu den Behandelnden“ und „Einstellungen und Überzeugungen“. Insgesamt wurden weitere 77 Unterkategorien gebildet und interpretiert. Das Adhärenzverhalten aus Patient*innensicht unterschied sich zwischen den verschiedenen Medikamentengruppen. Ein palliatives Setting beeinflusste Therapieentscheidungen und Therapieadhärenz. Die angewendeten Medikamentenschemata waren komplex und dynamisch, gerade auch bei mehreren beteiligten Behandelnden. Weiterhin bestand Unklarheit bei der Anwendung von Cannabinoiden. Nichtmedikamentöse Therapien wurden von den Patient*innen marginalisiert. Aus Sicht der befragten Patient*innen waren es weniger die Behandelnden, die Einfluss auf ihr Adhärenzverhalten nahmen, als vielmehr eigene Erfahrungen, Einstellungen und Überzeugungen Diskussion: Die Untersuchung bezog ergänzend zu bisheriger Literatur in einem qualitativen Setting alle Medikamentengruppen und auch nichtmedikamentöse Therapien gleichgestellt mit ein. Aus der bisherigen Forschung bekannte Adhärenzfaktoren spiegelten sich auch in der subjektiven Wahrnehmung der Gruppe der Patient*innen mit chronifizierten Schmerzen nach Tumorerkrankungen wider. Eine Marginalisierung nichtmedikamentöser Verfahren könnte damit erklärt werden, dass in der Phase einer Chronifizierung multimodale Therapieansätze zu selten konsequent eingesetzt und kontrolliert werden. Medikamentöse und nichtmedikamentöse Therapien sollten daher noch konsequenter auch bei Patient*innen mit tumorassoziierten Schmerzen gleichberechtigt angewendet werden.
- Open Access
- 27 October 2023
- Published by Cambridge University Press (CUP) in Palliative and Supportive Care
- Vol. 21 (6) , 1095-1096
Hidden persons in dignity therapy: The transcriptionists experiences in-between
- 27 October 2023
- Published by Cambridge University Press (CUP) in Palliative and Supportive Care
- Vol. 21 (6) , 1095-1096
Open AccessHidden persons in dignity therapy: The transcriptionists experiences in-between